ZS Pharma, Inc. Net Change in Cash
ZS Pharma, Inc. reported Net Change in Cash of $16.95 million for the 9-month period ending 2015-09-30, per its 10-Q filed 2015-11-09.
Discontinued › Cash Flow
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2015-11-09
- ZS Pharma, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2015-09-30 was -$13.07M.
- ZS Pharma, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2015-06-30 was -$135.97M, a 228.07% decline year-over-year.
- ZS Pharma, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2015-03-31 was $165.99M, a 1032.04% increase year-over-year.
- ZS Pharma, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2014-12-31 was -$74.13M.
- ZS Pharma, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2014 was $38.23M.
- ZS Pharma, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2013 was -$15.23M, a 173.39% decline from fiscal 2012.
- ZS Pharma, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2012 was $20.75M.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month |
|---|---|---|---|---|
| 2015-09-30 | -$13.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | -$149.05M derived: sum of 2 quarters · filed 2015-11-09 | $16.95M 10-Q · filed 2015-11-09 | -$57.19M derived: sum of 4 quarters · filed 2015-11-09 |
| 2015-06-30 | -$135.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $30.02M 10-Q · filed 2015-08-06 | -$44.12M derived: sum of 3 quarters · filed 2015-08-06 | -$52.58M derived: sum of 4 quarters · filed 2015-11-09 |
| 2015-03-31 | $165.99M 10-Q · filed 2015-05-11 | $91.86M derived: sum of 2 quarters · filed 2015-05-11 | $83.39M derived: sum of 3 quarters · filed 2015-11-09 | $189.56M derived: sum of 4 quarters · filed 2015-11-09 |
| 2014-12-31 | -$74.13M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-13 | -$82.60M derived: sum of 2 quarters · filed 2015-11-09 | $23.57M derived: sum of 3 quarters · filed 2015-11-09 | $38.23M 10-K · filed 2015-03-13 |
| 2014-09-30 | -$8.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $97.70M derived: sum of 2 quarters · filed 2015-11-09 | $112.36M 10-Q · filed 2015-11-09 | $104.48M derived: sum of 4 quarters · filed 2015-11-09 |
| 2014-06-30 | $106.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $120.83M 10-Q · filed 2015-08-06 | $112.95M derived: sum of 3 quarters · filed 2015-08-06 | $118.91M derived: sum of 4 quarters · filed 2015-08-06 |
| 2014-03-31 | $14.66M 10-Q · filed 2015-05-11 | $6.78M derived: sum of 2 quarters · filed 2015-05-11 | $12.74M derived: sum of 3 quarters · filed 2015-05-11 | |
| 2013-12-31 | -$7.88M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-13 | -$1.92M derived: sum of 2 quarters · filed 2015-03-13 | -$15.23M 10-K · filed 2015-03-13 | |
| 2013-09-30 | $5.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | -$7.35M 10-Q · filed 2014-11-10 | ||
| 2013-06-30 | -$13.31M 10-Q · filed 2014-08-14 | |||
| 2012-12-31 | $20.75M 10-K · filed 2015-03-13 |